SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Bob Marley — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientBob Marley
Date of birth1945-02-06
IdentifiersMRN HR-ML027-SYN-TD; SSN (made up) 000-27-4065
Document date1977-06-17
AuthorDesmond Clarke, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Toenail biopsy result and surgical oncology consultation. [S]

History of Present Illness

Mr. Marley returns nine days after his first visit. The clinic's dermatologist examined the nail with dermoscopy two days after that visit, found a band with irregular lines of varying color and spacing and pigment on the nail fold, and took a full-thickness excisional biopsy of the nail matrix under a digital block. The biopsy shows acral lentiginous melanoma, 0.8 mm thick, not ulcerated. The biopsy site has healed under the dressing; he has needed no pain medicine. He has no lumps in the groin or behind the knee, no cough, headache, or weight loss. Dr. Mbeki-Rowe of surgical oncology saw him this morning and went through the choices for surgery with him at length. He said that his faith, his music and his football all matter to him in this decision, and that he would like to keep the toe if that can be done without lowering his chance of cure. He has had no thoughts of self-harm. [S]

ElementDetail
DiagnosisAcral lentiginous melanoma of the right great toe nail unit, Breslow 0.8 mm, not ulcerated, mitotic rate 1 per mm2
Clinical stageIB (cT1b N0 M0); no symptoms of spread
Biopsy siteHealing; no pain medicine needed
CoordinationSurgical oncology seen this morning; surgery planned in two weeks
What matters to himHis faith, his music and his football; keeping the toe if that is safe

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo weight loss, fever, or night sweats
RespiratoryNegativeNo cough or breathlessness
NeurologicalNegativeNo headache or weakness
IntegumentaryNegativeNo other new or changing spots, bands, or sores
Hematologic and lymphaticNegativeNo lumps in the groin or behind the knee
PsychiatricPositiveWorried about the operation and touring; PHQ-9 4, GAD-7 6; no thoughts of self-harm

6 systems reviewed. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1977-06-17Body height170cmS
1977-06-17Body weight66.2kgS
1977-06-17Body mass index (BMI) [Ratio]22.9kg/m2S
1977-06-17Systolic blood pressure124mm[Hg]S
1977-06-17Diastolic blood pressure78mm[Hg]S
1977-06-17Heart rate70/minS
1977-06-17Respiratory rate14/minS
1977-06-17Body temperature36.6CelS
1977-06-17Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1977-06-17Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]4{score}S
1977-06-17Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]6{score}S

Physical Exam

Vital signs recorded on 1977-06-17; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 124/78, pulse 70; weight 66.2 kg
Right great toeBiopsy site healing over the proximal nail; the remaining nail plate shows the distal part of the brown-black band; pigment on the proximal nail fold; no nodule or ulcer
Lymph nodesNo right popliteal or inguinal nodes; no left inguinal, axillary, or cervical nodes
Skin and nailsWhole skin examined, including the scalp, palms, soles, between the toes, and all nails: no other suspicious lesion
AbdomenSoft; liver not enlarged
PsychiatricCalm, thoughtful; asks careful questions

Problems

ProblemClinical statusVerificationCodeProvenance
A brown-black band in the right great toenail, about 5 mm wide (about a third of the nail), with irregular dark lines, first noticed about two months ago after a knock at football and not growing out with the nail; the pigment extends onto the skin of the proximal nail fold (Hutchinson sign). Suspected subungual melanoma; dermoscopy and a full-thickness nail matrix biopsy booked this weekresolvedconfirmed L60.8S — Synthetic presenting problem linked to his documented toe lesion; superseded by the diagnosis at the surgical oncology consultation.
Acral lentiginous melanoma of the nail unit (subungual) of the right great toe, on full-thickness nail matrix biopsy: Breslow thickness 0.8 mm, not ulcerated, mitotic rate 1 per mm2, no lymphovascular or perineural invasion; clinical stage IB (cT1b N0 M0); synthetic modern detail linked to his documented acral lentiginous melanomaactiveconfirmed C43.71S — Synthetic thickness and stage; the site, the subtype, and the year are documented (D).

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
LaboratoryBiopsy pathology: Breslow thickness, ulceration, mitotic rate, margins, and microsatellitesAt diagnosisUp to date0.8 mm, not ulcerated, mitotic rate 1 per mm2, no lymphovascular or perineural invasion, no microsatellites; melanoma in situ at the lateral edges
ExaminationDermoscopy of the nailAt presentation with a pigmented nail bandUp to dateBy the dermatologist two days after the first visit: irregular lines and pigment on the nail fold
ExaminationFull skin and nail examination, including the scalp, palms, soles, between the toes, and all nailsAt diagnosis, then at each surveillance visitDeferredA deviation: the dermatologist examined the hands, feet and nails at the biopsy visit, but a full skin examination at diagnosis was not recorded. Dr. Clarke examined the whole skin today and found no other suspicious lesion, so no harm resulted. Corrective action: a yearly full skin examination by dermatology is booked, and the full examination is part of each surveillance visit
ExaminationExamination of the lymph node basins (right popliteal and inguinal) and the scarAt diagnosis, then at each surveillance visitCompleted todayNo palpable nodes
ImagingImaging (CT, PET, or ultrasound) and LDHNot routine for stage I to II without symptomsNot indicatedClinical stage IB without symptoms; scans and LDH would not change management
ReferralSentinel lymph node biopsyDiscussed and offered for T1b melanomaOrderedAccepted; with the excision in two weeks, after lymphoscintigraphy
ReferralSurgical oncologyAt diagnosis of invasive melanomaCompleted todaySeen this morning; recommendations in the consultation note
Self-managementShared decision on the extent of surgeryBefore definitive surgeryCompleted todayAmputation and digit-sparing excision explained with their outcomes; he chose digit-sparing excision; written summary given
LaboratoryGermline genetic testingOnly with several primary melanomas or a strong family history of melanoma or pancreatic cancerNot indicatedA single primary melanoma; no criterion met
SurveyDistress and depression screen (PHQ-9)At diagnosisCompleted todayPHQ-9 4 and GAD-7 6; no thoughts of self-harm

Goal progress:

Guideline basis: NCCN Clinical Practice Guidelines in Oncology: Melanoma: Cutaneous, Version 3.2026 (2026); Swetter SM, et al. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol 2019;80(1):208-250 (2019); Gershenwald JE, et al. Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin 2017;67(6):472-492 (2017); Wong SL, et al. Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update. J Clin Oncol 2018;36(4):399-413 (2018); Chouquet L, et al. Reconstruction After Wide Excision of the Nail Apparatus in the Treatment of Melanoma: A Systematic Literature Review. J Clin Med 2025;14(17):5932 (2025); Depression and Suicide Risk in Adults: Screening (2023)

Follow-up: Surgery in two weeks with Dr. Mbeki-Rowe. Review two weeks after surgery with the final pathology. Call for a lump in the groin, or for redness or discharge at the biopsy site. Next scheduled visit 1977-07-15: review two weeks after digit-sparing excision and sentinel node biopsy: final pathology and stage, graft care, and the surveillance plan. [S]